ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Shareholders’ equity 2016–2024
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) shareholders’ equity at each fiscal year-end, per SEC filings.
$11.8MFY2024 · since FY2016: $166.1M → $11.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $11.8M | -70.0% |
| FY2023 | $39.5M | -51.7% |
| FY2022 | $81.9M | -60.2% |
| FY2021 | $206.0M | -39.6% |
| FY2020 | $341.2M | +176.0% |
| FY2019 | $123.6M | -49.9% |
| FY2018 | $246.9M | +21.6% |
| FY2017 | $203.0M | +22.2% |
| FY2016 | $166.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice